D013 PPAR-alpha is essential for microparticleinduced differentiation of bone marrow-derived endothelial progenitor cells and in vitro angiogenesis  by Benameur, T. et al.
S40 Abstracts
Methods — MSC from C57Bl/6 mice bone marrow were transfected 
with SCF cDNA cloned into pcDNA-3, and a stable transfectant was 
selected in G418 medium. C57Bl/6 mice (N) underwent coronary 
ligation and received medium (M), or 3x105 MSC (C) or MSC 
transfected with SCF (CS) into the anterior left ventricle. Cardiac 
function was assessed by pressure-volume (PV) loops on day 28 
(n=10 per group). Hearts were perfusion- xed in situ and cut into 
transverse sections for computerized planimetry (n=5 per group).
Results — When measured in vivo, myocardial SCF increased 2.9-
fold in M, 5.5-fold in C, and 17.3-fold in SC groups compared to the 
N group (P<0.05). All analysis showed signi cant improvement of 
post MI ventricular size and function in cell groups compared to M 
group. PV loop analysis showed a 1.9-fold increase (P < 0.001) in 
the slope of preload-recruitable stroke work in CS group compared 
with C group. The improvement in end-systolic elastance was 
similar to the improvement in preload-recruitable stroke work. In 
addition, the left ventricular volume was 0.6-fold smaller (P<.01) 
in the CS group compared with the C group. However 4 out of 20 
survivors in CS group developed  brosarcomas in ltrating into the 
cell transplanted area within 3 months of cell implantation.
Conclusions — Use of genetically modi ed MSC over-expressing 
SCF better prevented ventricular dilation and restored cardiac 
function following MI. Unfortunately, this approach was associated 
with tumorogenesis and our data strongly suggests that malignant 
transformation was caused by the speci c combination of 
techniques that we used to generate our cell line.
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Therapeutic angiogenesis is a promising approach to re-establish 
cardiac perfusion following ischemia or in heart failure. Recently, 
it has been proposed that a combination of growth factors may be 
key to the generation of stable vascular networks. However, it is 
currently unknown what growth factor combinations are optimal 
for therapeutic angiogenesis and what mode of administration is 
most adapted to achieve functional revascularization of the heart.
The aim of this study was to investigate the effects of novel growth 
factor combinations and to evaluate their angiogenic effects in 
vivo following delivery with a new biodegradable polymer system.
First, we found that FGF-2 (Fibroblast Growth Factor-2) and HGF 
(Hepatocyte Growth Factor) display synergistic stimulatory effects 
on the migration and proliferation of murine endothelial cells in 
vitro. Furthermore, we show that whereas HGF potentiates the 
proliferative effect of FGF-2 in smooth muscle cells, the HGF-
induced mobility response in these cells is enhanced by FGF-2. 
The molecular mechanisms of the reciprocal stimulatory effects 
involve upregulation in endothelial cells of the HGF receptor, 
c-Met, by FGF-2, and vice versa upregulation of the FGFR-1 by HGF 
stimulation.
Next, we determined the release potential of a new polymeric 
delivery system based on biodegradable alginate microparticules 
adapted for cardiac injection. We found that FGF-2 is liberated 
during less than 1 month with a strong initial level of release during 
the  rst ten days. In contrast, HGF is continuously liberated during 
40 days with a maximal release around day eighth. Our in vivo data, 
from a Matrigel plug assay in mice, indicate a signi cantly increased 
ef cacy of angiogenic therapy using growth factors delivered by 
alginate polymers. Moreover, we found that a combination of HGF 
and FGF-2 displays a potent synergistic angiogenic effect in vivo.
In conclusion, we demonstrate the potential of the speci c 
combination of FGF-2 and HGF in obtaining a synergistic stimulatory 
effect in vitro and in vivo. Further, our new alginate-based 
injectable polymeric system seems well adapted for delivery of 
growth factors for therapeutic angiogenic approaches to ameliorate 
cardiac perfusion
D013
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Bone marrow-derived endothelial progenitor cells (EPCs), present in 
the systemic circulation, are augmented in response to tissue ischemia, 
and incorporate into sites of neovascularization. They possess the 
ability to differentiate into endothelial cells (ECs). Microparticles 
(MPs), small fragments generated from the plasma membrane, are 
able to activate the angiogenic program of ECs through mRNA transfer. 
Also, Peroxisome Proliferator-Activated Receptor (PPAR) alpha agonists 
increase cardiac progenitor differentiation. Here, we have studied the 
effects of circulating MPs obtained from PPARalpha wild type (WT) and 
knock-out (KO) mice on EPC differentiation and in vitro capillary-like 
tube formation of ECs.
MPs were obtained from blood of mice, and MP sub-populations 
were characterized by  ow cytometer. EPCs were isolated from WT 
mice using density gradient separation. Isolated cells were cultured 
in the absence or presence of MPs from PPARalpha WT or KO mice 
for 7 days. Then, expression of speci c markers of EPCs (Sca-1/
Flk-1) were analysed by  ow cytometry or dual binding of FITC-
labeled BS I lectin and Dil-acetylated-LDL by confocal microscopy. 
Also, ECs were isolated from WT mice aorta. The effects of 24 
hours incubation with MPs from PPARalpha WT or KO mice on in 
vitro angiogenesis were assessed by capillary-like tube formation 
assay on Matrigel.
Circulating MPs from PPARalpha mice were mainly derived 
from platelets and leucocytes. MP levels were not signi cantly 
different between strains. Only MPs from PPARalpha WT mice 
harbored PPARalpha. Incubation of EPCs with MPs from PPARalpha 
WT, but not from KO mice, increased signi cantly the number of 
differentiated EPCs. Incubation of ECs with PPARalpha WT-derived 
MPs increased capillary-like tube formation of ECs. By contrast, 
deletion of PPARalpha markedly inhibited in vitro tube formation 
of ECs.
Our results suggest that the presence of PPARalpha in MPs, not 
only stimulates EPCs differentiation, but also favored in vitro 
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angiogenesis of ECs. These  ndings provide a new alternative 
approach for cell therapy of cardiovascular pathologies associated 
with impaired angiogenesis that might include injection of EPCs 
treated with PPARalpha MPs.
Supported by Fondation de France.
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Objectif — La thérapie cellulaire basée sur l’utilisation de cellules 
progénitrices endothéliales (CPE) issues de la moelle osseuse ou du 
sang périphérique permet d’améliorer la neovascularisation après 
un infarctus du myocarde. Cependant, les cellules utilisées lors 
de telles thérapies sont souvent hétérogènes, et leur mécanisme 
d’action mal connu : réelle incorporation dans la paroi vasculaire 
ou effet paracrine promouvant l’angiogenèse ? Ainsi, nous avons 
voulu identi er quelle sous-population de cellules mononucléées 
issues de la moelle osseuse de souris contenait le plus de CPE 
ayant la capacité de générer des cellules endothéliales matures 
en culture.
Méthodes — Nous avons évalué différentes techniques de sélection : 
la séparation par gradient de densité qui permet d’obtenir des 
cellules mononucléées, les sélections magnétiques « Lineage 
negative » (Lin-), Sca-1+, et c-kit+ ainsi que la sélection c-kit+/
VEGFR-2+. L’expression des marqueurs endothéliaux matures a été 
étudiée par immunocytochimie, cytométrie en  ux, et RT-PCR sur 
les colonies obtenues.
Résultats — Les colonies apparaissaient au 8e jour de culture. Le 
tri Lin- permettait d’obtenir le plus grand nombre de colonies par 
rapport aux autres tris. Les analyses immunocytochimiques et 
cytométriques montraient qu’à l’intérieur des colonies Lin-, c-kit+ 
et de celles dérivant des cellules mononucléées, une majorité de 
cellules était LDL+, Lectine+, VEGFR-2+, CD31+ et CD144+, c’est-
à-dire à caractère endothélial mature. Cependant, les colonies 
dérivées des cellules mononucléées semblaient également contenir 
des cellules  broblastiques comme le montrait une expression plus 
importante du gène FSP-1. Par ailleurs, la cytométrie en  ux a 
montré que les colonies Sca-1+ n’avaient majoritairement pas un 
phénotype endothélial (1 à 2 % de cellules VEGFR-2+ et CD31+), et 
que 35 % des cellules exprimaient le CD11b, correspondant à un 
phénotype monocytaire.
Conclusion — La population cellulaire Lin- issue de la moelle 
osseuse de souris est une source importante de CPE. En effet, la 
culture de cellules Lin- parait être la plus adaptée pour générer 
des cellules endothéliales matures, si on la compare à la culture 
de cellules Sca-1+, c-kit+ ou de cellules mononucléées. La 
population Lin- constituerait donc une cible de choix pour la 
thérapie cellulaire destinée à stimuler la vasculogenèse.
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Background and aim — VEGF-A has been described to be an important 
pro-angiogenic factor. Immune cells are intimately involved in tissue 
repair and neovascularisation notably by their capacity to secrete 
VEGF-A. Moreover, these cells possess mineralocorticoid receptors. 
The present study was designed to investigate whether aldosterone 
(Aldo) was able to regulate VEGF-A production of immune cells.
Methods — HL-60 (progranulocytic) and THP-1 (promonocytic) cell 
lines and human blood neutrophils and monocytes were incubated 
for different times with Aldo (10-7, 10-8, 10-9 M). Total cellular 
RNA extraction, submitted to reverse transcription and real time 
quantitative PCR was used to study VEGF-A mRNA expression. Cell 
supernatants were collected and ELISA tests were performed to 
analyse VEGF-A protein excretion.
Results — All four cell types increased their VEGF-A mRNA and 
protein production. VEGF-A mRNA expression increased from 30 mn 
and time for maximal expression depended on cell type: 30 mn 
for HL-60 and THP-1 cells, and for blood neutrophils 3 hours after 
Aldo addition. ELISA tests showed increased excretion of VEGF-A 
proteins after 24 hours of Aldo contact for all four cell types. 
Western-blotting performed with HL-60 and THP-1 cells showed 
that ERK1/2 and p38 pathways are stimulated by Aldo. ERK1/2, p38 
and PI3kinase transduction signal inhibitors decreased this immune 
cell activation orchestrated by Aldo.
Conclusion — We have demonstrated that Aldo is able to increase 
VEGF-A production of phagocytic cells such as neutrophils and 
monocytes. This phenomenon is PI3K, ERK1/2 and p38 dependent. 
These cells play an important role in tissue healing notably by 
their capacity to degrade dead cells and to secrete pro-angiogenic 
factors such as VEGF-A in situ. It appears that Aldo could play an 
important role in this neovascularisation process by favouring cell 
proliferation and tissue building.
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Hypoxia is a potent inducer of angiogenesis during which endothelial 
cells (ECs) undergo modulations of cell-cell and cell-matrix 
interactions. ANGPTL4 expression is induced by hypoxia in ECs 
(1,2) and interacts with the extracellular matrix (3) modulating 
ECs adhesion, migration and sprouting through cytoskeleton 
reorganisation (4).
Objective — Analyse whether in vivo ANGPTL4 plays a role in 
modulating hypoxia-driven angiogenesis in the retina, both in 
development and in vascular retinal pathologies.
Materials — C57/Bl6 angptl4 KO mice and WT littermates were used. 
An hyperoxia chamber was used to establish the oxygen-induced 
retinopathy (OIR). Mice were exposed to 75 % oxygen from P7 to P12 
leading to retinal vessel loss. After returning to room air, hypoxia 
induces neovascularisation, evaluated at P17 when greatest.
